Global Rapid Microbiology Testing Market Growth (Status and Outlook) 2023-2029

Global Rapid Microbiology Testing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Rapid Microbiology Testing Industry Forecast” looks at past sales and reviews total world Rapid Microbiology Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Microbiology Testing sales for 2023 through 2029. With Rapid Microbiology Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Microbiology Testing industry.

This Insight Report provides a comprehensive analysis of the global Rapid Microbiology Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Microbiology Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Microbiology Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Microbiology Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Microbiology Testing.

The global Rapid Microbiology Testing market size is projected to grow from US$ 4104.2 million in 2022 to US$ 6241.7 million in 2029; it is expected to grow at a CAGR of 6.2% from 2023 to 2029.

Based on method, the global rapid microbiology testing market is divided into five segments growth- based, viability-based, cellular component-based, nucleic acid-based, and Others testing methods. The growth-based rapid microbiology testing segment is expected to account for the largest share of the market in 2018.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Microbiology Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Growth-Based
Viability-Based
Cellular Component-Based
Nucleic Acid-Based
Others

Segmentation by application
Diagnostic Laboratories & Hospitals
Pharmaceutical & Biotechnology Companies
Food & Beverage Companies
Contract Research Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
BD
Merck
Bruker
Danaher
Thermo Fisher Scientific
Biomerieux
Charles River Laboratories
Neogen
TSI
Quidel Corporation
Vivione Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.